• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tandem Diabetes Care adds two new members to its board

June 16, 2022 By Sean Whooley

Tandem Diabetes Care tslim_X2_Insulin_Pump_Front_View_Control-IQ_RGB
Image from Tandem Diabetes

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed two new independent members to its board of directors.

Myoung Cha and Joao Malagueira have been named to the San Diego-based automated insulin delivery technology developer’s board, effective yesterday.

“We welcome Joao and Myoung to our board of directors at this exciting stage in Tandem’s evolution,” Tandem President and CEO John Sheridan said in a news release. “Joao’s extensive international experience brings tremendous value to our company as we continue to expand our global reach, and Myoung’s strategic experience in leading-edge consumer technology at large companies will be invaluable as we advance our product pipeline.”

Cha has picked up experience totaling more than 17 years across the healthcare value chain and currently serves as chief strategy officer of Carbon Health, where he leads the omnichannel care model and the device-enabled home care operations.

Before Carbon Health, which he joined in June 2021, Cha was head of health strategic initiatives at Apple for nearly six years, developing and leading product initiatives and global strategic partnerships. He’s also held roles with the West Coast Strategy and Corporate Finance Practice and the Healthcare Investor Practice at McKinsey & Co.

Malagueira joins Tandem’s board with more than 25 years of experience in diabetes, medical devices and diagnostics at global corporations.

He currently serves as VP for three divisions at Hologic and has responsibility for the company’s entire portfolio in the EMEA. Before this role at Hologic, which he assumed in January 2019, Malagueira was international VP for EMEA and Canada for Hologic’s diagnostics solutions division, a position he held for more than three years.

Malagueira also spent more than 15 years at Johnson & Johnson in commercial leading roles across EMEA. He led turnarounds and market share growth for the diabetes solutions businesses at J&J, LifeScan and Animas.

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Personnel, Technology Tagged With: Personnel, Personnel Moves, Tandem Diabetes Care

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS